Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$618M |
| 2 |
Vale
VALE
|
+$332M |
| 3 |
CELG
Celgene Corp
CELG
|
+$309M |
| 4 |
CME Group
CME
|
+$306M |
| 5 |
Amazon
AMZN
|
+$290M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$435M |
| 2 |
Meta Platforms (Facebook)
META
|
+$342M |
| 3 |
Crown Castle
CCI
|
+$244M |
| 4 |
SLB Ltd
SLB
|
+$229M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.17% |
| 2 | Technology | 14.41% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Financials | 10.51% |
| 5 | Real Estate | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Arrow Financial
AROW
$659M
| $11.3M | 0.01% |
399,996
+12,288
| +3% | +$357K |
|
1302
AngioDynamics
ANGO
$611M
| $11.3M | 0.01% |
495,946
-84,954
| -15% | -$1.84M |
|
1303
Timberland Bancorp
TSBK
$348M
| $11.3M | 0.01% |
405,066
+4,766
| +1% | +$134K |
|
1304
Huron Consulting
HURN
$2.41B
| $11.3M | 0.01% |
239,458
+63,400
| +36% | +$3.13M |
|
1305
Acacia Research
ACTG
$428M
| $11.3M | 0.01% |
3,463,500
+124,700
| +4% | +$387K |
|
|
QIWI
1306
DELISTED
QIWI PLC
QIWI
| $11.3M | 0.01% |
784,380
+255,400
| +48% | +$3.74M |
|
|
DCOM
1307
DELISTED
Dime Community Bancshares
DCOM
| $11.3M | 0.01% |
602,300
+175,400
| +41% | +$3.38M |
|
|
EMCI
1308
DELISTED
EMC INS Group Inc
EMCI
| $11.3M | 0.01% |
352,973
+33,204
| +10% | +$1.06M |
|
1309
NVE Corp
NVEC
$562M
| $11.2M | 0.01% |
114,900
-4,600
| -4% | -$444K |
|
1310
Sun Life Financial
SLF
$46B
| $11.2M | 0.01% |
292,600
-197,100
| -40% | -$7.23M |
|
|
KIN
1311
DELISTED
Kindred Biosciences, Inc.
KIN
| $11.2M | 0.01% |
1,222,398
+123,810
| +11% | +$1.26M |
|
|
EPAY
1312
DELISTED
Bottomline Technologies Inc
EPAY
| $11.2M | 0.01% |
223,242
-15,900
| -7% | -$768K |
|
1313
STMicroelectronics
STM
$46.7B
| $11.2M | 0.01% |
752,424
-1,535,764
| -67% | -$23.8M |
|
1314
Inseego
INSG
$114M
| $11.1M | 0.01% |
235,880
+62,850
| +36% | +$3.21M |
|
1315
Oppenheimer Holdings
OPY
$1.14B
| $11.1M | 0.01% |
427,100
+25,000
| +6% | +$678K |
|
1316
Regional Management Corp
RM
$301M
| $11.1M | 0.01% |
454,937
+9,937
| +2% | +$265K |
|
1317
Gran Tierra Energy
GTE
$265M
| $11.1M | 0.01% |
488,100
-1,897
| -0.4% | -$44.5K |
|
1318
Bank of Marin Bancorp
BMRC
$472M
| $11.1M | 0.01% |
272,211
+31,000
| +13% | +$1.32M |
|
1319
Anika Therapeutics
ANIK
$258M
| $11.1M | 0.01% |
365,410
+102,277
| +39% | +$3.5M |
|
1320
Manchester United
MANU
$3.97B
| $11M | 0.01% |
573,200
+72,200
| +14% | +$1.41M |
|
1321
TechTarget
TTGT
$325M
| $11M | 0.01% |
675,404
-535,596
| -44% | -$8.04M |
|
|
CJ
1322
DELISTED
C&J Energy Services, Inc.
CJ
| $11M | 0.01% |
706,200
+647,400
| +1,101% | +$10.4M |
|
1323
IDT Corp
IDT
$1.64B
| $11M | 0.01% |
1,649,197
+114,600
| +7% | +$764K |
|
|
EXAS
1324
DELISTED
Exact Sciences
EXAS
| $10.9M | 0.01% |
+126,200
| New | +$10.7M |
|
1325
AeroVironment
AVAV
$7.56B
| $10.9M | 0.01% |
159,636
-78,000
| -33% | -$5.88M |
|
Similar funds
Renaissance Technologies's Q1 2019 Portfolio in Review
As of Q1 2019, Renaissance Technologies held 3,883 positions worth $110B, up 20% from $91.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Renaissance Technologies deployed $7.09B of net new capital in Q1 2019, opening 532 new positions and adding to 1,751 existing holdings. Its largest new stake was Amazon: 3,483,100 shares worth $310M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $342M trimmed.
- Renaissance Technologies's largest Q1 2019 buy was Amazon: 3,483,100 shares worth $310M.
- Renaissance Technologies added most to Starbucks in Q1 2019, an estimated $618M increase.
- Renaissance Technologies's biggest Q1 2019 reduction was Meta Platforms (Facebook), cutting an estimated $342M.
- Renaissance Technologies fully exited Apple in Q1 2019, selling an estimated $435M.
- Renaissance Technologies's ten largest holdings make up 8.7% of its $110B portfolio in Q1 2019.
- Renaissance Technologies opened 532 new positions and closed 465 in Q1 2019.
- Renaissance Technologies's portfolio value rose 20% quarter-over-quarter to $110B.
Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.